These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32959021)

  • 1. Expanded mesenchymal stem cells: a novel therapeutic approach for SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain.
    Soler Rich R; Rius Tarruella J; Melgosa Camarero MT
    Med Clin (Engl Ed); 2020 Oct; 155(7):318-319. PubMed ID: 32959021
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded Mesenchymal Stem Cells: a novel therapeutic approach of SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain.
    Soler Rich R; Rius Tarruella J; Melgosa Camarero MT
    Med Clin (Barc); 2020 Oct; 155(7):318-319. PubMed ID: 32753110
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
    Akbari A; Rezaie J
    Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
    Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia.
    Chu M; Wang H; Bian L; Huang J; Wu D; Zhang R; Fei F; Chen Y; Xia J
    Stem Cell Rev Rep; 2022 Aug; 18(6):2152-2163. PubMed ID: 35665467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Gholizadeh O; Youshanlouei HR; Matloub SK; Mozafari M; Jokar E; Yazdani Y; Dadashpour M
    Stem Cell Res Ther; 2022 Jun; 13(1):257. PubMed ID: 35715852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery.
    Couto PS; Al-Arawe N; Filgueiras IS; Fonseca DLM; Hinterseher I; Catar RA; Chinnadurai R; Bersenev A; Cabral-Marques O; Moll G; Verter F
    Front Immunol; 2023; 14():1200180. PubMed ID: 37415976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use.
    Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Corsico AG
    Cells; 2020 Apr; 9(4):. PubMed ID: 32283815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
    Akkoc T
    Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems.
    Kodama T; Obinata H; Mori H; Murakami W; Suyama Y; Sasaki H; Kouzaki Y; Kawano S; Kawana A; Mimura S
    J Infect Chemother; 2021 Feb; 27(2):336-341. PubMed ID: 33402303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol.
    Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
    Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of SARS-CoV-2 pneumonia diagnosed in a primary care practice in Madrid (Spain).
    Guisado-Clavero M; Herrero Gil A; Pérez Álvarez M; Castelo Jurado M; Herrera Marinas A; Aguilar Ruiz V; Gefaell Iarrondo I; Menéndez Orenga M; Ares-Blanco S
    BMC Fam Pract; 2021 Apr; 22(1):83. PubMed ID: 33926382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
    Yadav P; Vats R; Bano A; Bhardwaj R
    Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave.
    Carrasco I; Muñoz-Chapuli M; Vigil-Vázquez S; Aguilera-Alonso D; Hernández C; Sánchez-Sánchez C; Oliver C; Riaza M; Pareja M; Sanz O; Pérez-Seoane B; López J; Márquez E; Domínguez-Rodríguez S; Hernanz-Lobo A; De León-Luis JA; Sánchez-Luna M; Navarro ML
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):326. PubMed ID: 33902483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.